New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease

Pharmazie

Volumn 61, Issue 4, 2006, Pages 269-273

  Szymanski P ^a   Zurek, E ^a   Mikiciuk Olasik, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDRAZINO 1 [2 (1,2,3,4 TETRAHYDROACRIDIN 9 YLAMINO)ETHYL]NICOTINAMIDE; 6 HYDRAZINO N [3 (1,2,3,4 TETRAHYDROACRIDIN 9 YLAMINO)PROPYL]NICOTINAMIDE; 6 HYDRAZINO N [6 (1,2,3,4 TETRAHYDROACRIDIN 9 YLAMINO)HEXYL]NICOTINAMIDE; 6 HYDRAZINO N [8 (1,2,3,4 TETRAHYDROACRIDIN 9 YLAMINO)OCTYL]NICOTINAMIDE; ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; NICOTINAMIDE DERIVATIVE; TACRINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; DIAGNOSTIC VALUE; DRUG BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME SPECIFICITY; IC 50;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; HUMANS; HYDRAZINES; INDICATORS AND REAGENTS; KINETICS; NIACINAMIDE; RADIOPHARMACEUTICALS; TACRINE; TECHNETIUM COMPOUNDS;

EID: 33645766518     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Abrams MJ, Juweid M, TenKate CI, Schwartz DA, Hauser MM, Gaul FE, Fuccello AJ, Rubin RH, Strauss HW, Fischman AJ (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 31: 2022-2028.
2. Albert MS, Drachman DA (2000) Alzheimer's disease. What is it, how many people have it, and why do we need to known? Neurology 55: 166-168.
3. Camargo EE (2001) Brain SPECT in Neurology and Psychiatry. J Nucl Med 42: 611-623.
4. Carlier PR, Chow ES-H, Han Y, Liu J, Yazal JE, Pang Y-P (1999) Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions. J Med Chem 42: 4225-4231.
5. Carlier PR, Han YF, Chow ES-H, Li CP-L, Wang H, Lieu TX, Wong HS, Pang Y-P (1999) Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis. Bioorg Med Chem 7: 351-357.
6. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
7. Ellman GL, Courtney KD, Andres VJr, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.
8. Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer's disease: a revive of progress. J Neurol Neurosurg Psychiatry 66: 137-147.
9. Graeber MB, Mehraein P (1999) Reanalysis of the first case of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 249: Suppl. 3 III/10-III/13.
10. Hu M-K, Lu C-F (2000) A facile synthesis of bis-tacrine isosteres. Tetrahedron Lett 41: 1815-1818.
11. Jagust W (2004) Molecular neuroimaging in Alzheimer's disease. NeuroRx® 1: 206-212.
12. Kamiński ZJ (1985) 2-Chloro-4,6-disubstituted-1,3,5-triazines. A novel group of condensing reagents. Tetrahedron Lett 26: 2901-2904.
13. Kamiński ZJ (1987) 2-Chloro-4,6-dimethoxy-1,3,5-triazine. A new coupling reagent for peptide synthesis. Synthesis 10: 917-920.
14. Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST (2002) Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 72: 310-314.
15. Marco JL, De Los Rios C, Carreiras MC, Banos JE, Badia A, Vivas NM (2001) Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues. Bioorg Med Chem 9: 727-732.
16. O'Brien J, Barber B (2000) Neuroimaging in dementia and depression. Adv Psychiatr Treatm 6: 109-119.
17. Porcelli F, Delfini M, Del Giudice MR (1999) The kinetic inhibition of acetylcholinesterase from human erythrocyte by tacrine and some tacrine derivatives. Bioorg Chem 27: 197-205.
18. Recanantini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M, Caviarini V (2000) SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogs. J Med Chem 43: 2007-2018.